Clinical Trials Directory

Trials / Sponsors / Chen Xiaoping

Chen Xiaoping

Academic / Other · 17 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
RecruitingNeoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
HCC
Phase 22024-06-01
RecruitingPrecision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models
HCC, Precision Therapy
Phase 12024-06-01
Not Yet RecruitingEfficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learn
HCC
Phase 42024-05-01
RecruitingPrecision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
HCC
Phase 42024-04-01
RecruitingTriple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
HCC
Phase 42024-04-01
CompletedRecurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma
HCC - Hepatocellular Carcinoma
—2022-01-15
CompletedML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture
Peritoneal Metastasis
—2020-01-01
Active Not RecruitingComparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
Hepatocellular Carcinoma
N/A2019-12-01
RecruitingAdjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
Hepatocellular Carcinoma
N/A2019-12-01
UnknownSurgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
Hepatocellular Carcinoma, Liver Cirrhosis
—2019-08-01
UnknownChen's U-Suture Technique for Pancreaticojejunostomy Following Pancreaticoduodenectomy
Pancreaticoduodenectomy
N/A2019-06-24
CompletedPostoperative Adjuvant Therapy of HCC Based on PD-1
Hepatocellular Carcinoma, RFS
—2019-02-01
CompletedPostoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelli
Hepatocellular Carcinoma, Adjuvant Immunotherapy, Checkpoint Inhibitor
—2019-02-01
CompletedVETC is an Effective Marker for Postoperative Adjuvant Immunotherapy
HCC, Recurrence
—2019-01-01
Active Not RecruitingIntra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in
HCC, Adjuvant Therapy, Immunotherapy
—2019-01-01
CompletedA Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular Carcinoma
Long-term Effects of Cancer Treatment
—2015-02-14
CompletedComparison of Chen's U-suture Technique with Duct-to-Mucosa Anastomosis and Invagination Pancreaticojejunostom
Pancreaticoduodenectomy
—2014-01-01